Salman Waheeduddin
Rheumatology · Franklin, WINPI 1598700387
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.8%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 77.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $3,298 and has fallen 91.3% since, to $286 in 2024.
Across 53 payments — averaging $91.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Sanofi$287
- Amgen$204
- GSK$198
- Aurinia Pharma U.S., Inc.$144
- AstraZeneca$125
- plus $151 from 3 others
What the payments were for
- Consulting fees$2,80058%
- Travel & lodging$1202%
- Food & beverage$1,79937%
- Education$1253%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $3,735 |
| Sanofi | 8 | $287 |
| Amgen | 7 | $204 |
| GSK | 3 | $198 |
| Aurinia Pharma U.S., Inc. | 2 | $144 |
| AstraZeneca | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $100 |
| Celltrion USA Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,844 in reported general payments places this provider in the 80th percentile of 120 rheumatology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 227 | $2,093,400 |
| Enbrel SureclickEtanercept | 136 | $1,123,269 |
| Skyrizi PenRisankizumab-Rzaa | 51 | $1,033,249 |
| RinvoqUpadacitinib | 73 | $501,423 |
| BenlystaBelimumab | 70 | $351,566 |
| Taltz AutoinjectorIxekizumab | 27 | $337,692 |
| StelaraUstekinumab | 19 | $322,323 |
| OtezlaApremilast | 47 | $234,177 |
| XeljanzTofacitinib Citrate | 29 | $165,765 |
| TremfyaGuselkumab | 12 | $151,021 |
| Orencia ClickjectAbatacept | 25 | $142,023 |
| Enbrel MiniEtanercept | 15 | $129,861 |
| Xeljanz XrTofacitinib Citrate | 23 | $129,386 |
| Actemra ActpenTocilizumab | 31 | $102,526 |
| Humira(Cf)Adalimumab | 14 | $94,050 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Humira(Cf) | $3,735 | $595,47387 claims |
| GSKBenlysta | $198 | $351,56670 claims |
| AmgenOtezla | $204 | $234,17747 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 120 rheumatology providers in Wisconsin.
Other rheumatology in Franklin
- Kurt OelkeGlendale$750K
- Daniel MaloneBeaver Dam$505K
- John AlbertGlendale$369K
- Taraneh MehraniMenomonee Falls$176K
- Ekaterina SoforoSheboygan$159K
- Shikha SinglaMilwaukee$108K
- Eric AndersonOconomowoc$103K
- Isabelle AmiguesGreen Bay$80K
- Sara McCoyMadison$80K
- Mark PearsonBrookfield$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.